Posts filed under: Orthopedic Biomaterials
Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Baxter International Inc., a global leader in advancing surgical innovation, announced U.S. Food and Drug Administration (FDA) clearance of Actifuse Flow Bone Graft Substitute for use in...
Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure San Diego, California-based NuVasive, Inc. has announced the U.S. launch of AttraX Scaffold, the company’s absorbent ceramic-collagen bone graft with an optimized surface. According to the company,...
Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Datum Biotech Ltd. has announced the founding of Datum Orthobiologics Ltd. Datum Orthobiologics will focus on creating advanced biomaterials for orthopedics based on proven bone formation...
Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Medtronic plc announced U.S. Food and Drug Administration (FDA) approval of Infuse(TM) Bone Graft in new spine surgery indications. InfuseBone Graft is now approved for use...
Register to receive a free Orthopedic Biomaterials Market Report Suite for US 2017-2023 synopsis and brochure Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced the launch of OsteGro, an allograft bone matrix that supports new bone growth in orthopedic surgical...
Register to receive a free Orthopedic Biomaterials Market Report Suite for US 2017-2023 synopsis and brochure Biotechnology startup Molecular Matrix Inc. has received 510(k) FDA clearance for a carbohydrate-based polymer that can help injured bones heal and regrow, reports the University of...
Anika Therapeutics, Inc., a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, recently announced that its HA-based bone void filler received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and...
These newly introduced products join Trabexus EB, which first received 510(k) clearance in 2015. TRABEXUS EB is a self-setting, gradually resorbable, calcium phosphate matrix enhanced with partially demineralized allograft particles....
Bone graft substitutes are widely used in a variety of indications, including dental, spine, trauma, large joint, foot & ankle, craniomaxillofacial, and oncology....
Firm wants data on best dosage of controversial bone-growth product. ...
?
Want more information about the market report mentioned in this article?
Want more information about the market report mentioned in this article?
